UBS analyst Graham Doyle maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of €53.00.

Siemens Healthineers faces short-term challenges but offers long-term growth potential in imaging and radiation oncology, ...

Siemens Healthineers recently announced that it expanded its strategic partnership with The Ohio State University Wexner ...

Both are looking to drive innovation in diagnostic and therapeutic imaging as well as AI and machine learning in radiology ...

The partnership is valued at $105 million and the partners will co-develop technologies to improve patient care.

Siemens has developed a system for digital mammography that matches your demands: MAMMOMAT Inspiration. This mammography platform for screening, diagnostics, stereotactic biopsy, and 3D ...

Siemens Healthineers has agreed a €200 million ($224 million) deal to buy the diagnostic arm of Novartis' Advanced Accelerator Applications (AAA) radiopharma unit, boosting its medical imaging ...